First-line Ibrutinib Treatment is Associated with Longer Time to Next Treatment in a Real-World US Veterans Population
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA（2019）
关键词
ibrutinib,chemoimmunotherapy,CLL/SLL,chronic lymphocytic leukemia,time-to-next-treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要